Leonhard Müllauer
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 15
- Myeloproliferative Neoplasms: Diagnosis and Treatment 15
- Hematology top 1%
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 34
- Immunology top 2%
- Mast cells and histamine 25
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 14
-
- Cancer Genomics and Diagnostics 29
-
- Lung Cancer Treatments and Mutations 20
-
- Eosinophilic Disorders and Syndromes 15
- Co-authors
- Markus RadererPeter ValentAndreas ChottBerthold StreubelWolfgang R. SperrFelicitas OberndorferIngrid Simonitsch‐KluppJulius Lukas
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Leonhard Müllauer
190 papers receiving 5.2k citations
Peers
Comparison fields: 5 of 119
- Genetics 1.0k
- Hematology 829
- Pathology and Forensic Medicine 1.3k
- Immunology 1.2k
- Oncology 1.3k
Countries citing papers authored by Leonhard Müllauer
This map shows the geographic impact of Leonhard Müllauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonhard Müllauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonhard Müllauer more than expected).
Fields of papers citing papers by Leonhard Müllauer
This network shows the impact of papers produced by Leonhard Müllauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonhard Müllauer. The network helps show where Leonhard Müllauer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Leonhard Müllauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 13 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 14 | |
| 7 | 2022 | 7 | |
| 8 | 2021 | 10 | |
| 9 | 2020 | 3 | |
| 10 | 2020 | 7 | |
| 11 | 2020 | 15 | |
| 12 | 2019 | 1 | |
| 13 | 2017 | 6 | |
| 14 | 2017 | 17 | |
| 15 | 2015 | 66 | |
| 16 | 2015 | 19 | |
| 17 | 2014 | 81 | |
| 18 | 2009 | 89 | |
| 19 | 2009 | 45 | |
| 20 | 2008 | 132 |
About Leonhard Müllauer
Leonhard Müllauer is a scholar working on Genetics, Pathology and Forensic Medicine and Cancer Research, having authored 198 papers that have together received 5.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (34 papers), Cancer Genomics and Diagnostics (29 papers), Mast cells and histamine (25 papers), Lung Cancer Treatments and Mutations (20 papers), Chronic Lymphocytic Leukemia Research (15 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers), Eosinophilic Disorders and Syndromes (15 papers) and Cancer Immunotherapy and Biomarkers (14 papers). The work is most often cited by research in Genetics (1.0k citations), Hematology (829 citations) and Pathology and Forensic Medicine (1.3k citations). Leonhard Müllauer has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Markus Raderer, Peter Valent, Andreas Chott, Berthold Streubel, Wolfgang R. Sperr, Felicitas Oberndorfer, Ingrid Simonitsch‐Klupp, Julius Lukas, Bettina Grasl‐Kraupp and Marlene Troch. Their work appears in journals such as Blood, Oncotarget, Annals of Hematology, Cancers and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.